Stablix, Inc.
@StablixInc
Followers
81
Following
9
Statuses
10
Pioneering transformative medicines for targeted deubiquitination therapeutics (TPT)
New York, NY and Boston, MA
Joined June 2021
Check out the @WuXi_AppTec “BOLD: Innovation That Matters” event happening today. Hear from our CSO @EddineSaiah on how we’re expanding the definition of druggability by unlocking the power of targeted protein #deubiquination. Tune in: #TakingBOLDAction
0
1
2
How are we #TakingBOLDAction to pioneer targeted protein #deubiquitination therapeutics? Tomorrow, Chief Scientific Officer @EddineSaiah will share how we're aiming to redefine #druggability during @WuXi_AppTec’s “BOLD: Innovation That Matters." Register:
0
2
3
Why is our collaboration with @VertexPharma the perfect match? Our CEO, Tony Kingsley, explains: “We bring DUB biology and chemistry, they bring the target disease and disease expertise.” Check out the full article by @Nicole_DeFeudis of @endpts here! 👇
0
0
5
We’re thrilled to announce our collaboration with @VertexPharma to discover & develop #TPS (targeted protein stabilization) therapeutics. Learn how we’re exploring the potential of targeted protein #deubiquitination for patients in need of breakthroughs:
0
2
7
Our COO and co-founder, Kevin Sprott, is thrilled to speak in a panel discussion at the #wellsfargo 2023 Targeted Protein Degradation (#TPD) Virtual Summit tomorrow (2p EST), as we establish a new paradigm for restoring protein function.
0
1
0
@jaybradner @DanNomura @UCBerkeley @nchembio Great work highlighting the potential of #TPS. Exciting times ahead for this emerging modality! #inducedproximity
0
0
0
@DanNomura @nchembio @n_j_henning @lydiaboike @UCB_Chemistry @NovartisScience @TheMarkFdn Great to see the @DanNomura lab highlight the promise of #TPS to treat disease. Exciting times ahead for this emerging field!
0
0
2
Exciting start to the week. We are thrilled to welcome Tony Kingsley!
Tony Kingsley is taking charge at Stablix, a biotech startup out of Versant that announced a $63 million launch raise just a couple of months before the biotech exec found the exit at Scholar Rock.
0
0
1
RT @lisamjarvis: Versant-backed Stablix has launched to use heterobifunctional moecules to tap into the ubiquitin-proteasome system--but th…
0
2
0
We are excited to announce our Series A launch to pioneer this new therapeutic white space and address a number of devastating diseases! #targetedproteinstabilization #stablix #TPS
0
0
4